Where clinically indicated and after eligibility screening: Mounjaro (tirzepatide), Ozempic and Wegovy (semaglutide injectable), and generic semaglutide (post-March 2026 from Sun Pharma, Zydus, Dr
These findings contribute novel clinical data to the existing literature, which has largely inferred reproductive benefits from improvements in insulin sensitivity, androgen levels, and ovulatory cyclicity [14, 15]
With the combination of screened trials described in English, it was revealed that GLP-1RAs were much more prone to be applied for treatment of overweight/obese T2D patients than for non-obese T2D patients
However, the decision will depend on several factors, such as: Personal health profile : Your overall health, pre-existing conditions, and current medications can determine whether it is right for you
Plus its great to use it in the comfort of my own home